Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoyuki Tsuda

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer|June 30, 2025
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancerLaura Antonucci, Na Li, Angeles Duran, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer|June 30, 2025
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancerLaura Antonucci, Na Li, Angeles Duran, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 8